Federal Register / Vol. 61, No. 98 / Monday, May 20, 1996 / Notices 25247

Library, State University of New York,

Oswego, New York 13126. If a request

for a hearing or petition for leave to

intervene is filed by the above date, the

Commission or an Atomic Safety and

Licensing Board, designated by the

Commission or by the Chairman of the

Atomic Safety and Licensing Board

Panel, will rule on the request and/or

petition; and the Secretary or the

designated Atomic Safety and Licensing

Board will issue a notice of hearing or

an appropriate order.

As required by 10 CFR 2.714, a

petition for leave to intervene shall set

forth with particularity the interest of

the petitioner in the proceeding, and

how that interest may be affected by the

results of the proceeding. The petition

should specifically explain the reasons

why intervention should be permitted

with particular reference to the

following factors: (1) The nature of the

petitioner’s right under the Act to be

made party to the proceeding; (2) the

nature and extent of the petitioner’s

property, financial, or other interest in

the proceeding; and (3) the possible

effect of any order which may be

entered in the proceeding on the

petitioner’s interest. The petition should

also identify the specific aspect(s) of the

subject matter of the proceeding as to

which petitioner wishes to intervene.

Any person who has filed a petition for

leave to intervene or who has been

admitted as a party may amend the

petition without requesting leave of the

Board up to 15 days prior to the first

prehearing conference scheduled in the

proceeding, but such an amended

petition must satisfy the specificity

requirements described above.

Not later than 15 days prior to the first

prehearing conference scheduled in the

proceeding, a petitioner shall file a

supplement to the petition to intervene

which must include a list of the

contentions which are sought to be

litigated in the matter. Each contention

must consist of a specific statement of

the issue of law or fact to be raised or

controverted. In addition, the petitioner

shall provide a brief explanation of the

bases of the contention and a concise

statement of the alleged facts or expert

opinion which support the contention

and on which the petitioner intends to

rely in proving the contention at the

hearing. The petitioner must also

provide references to those specific

sources and documents of which the

petitioner is aware and on which the

petitioner intends to rely to establish

those facts or expert opinion. Petitioner

must provide sufficient information to

show that a genuine dispute exists with

the applicant on a material issue of law

or fact. Contentions shall be limited to

matters within the scope of the

amendment under consideration. The

contention must be one which, if

proven, would entitle the petitioner to

relief. A petitioner who fails to file such

a supplement which satisfies these

requirements with respect to at least one

contention will not be permitted to

participate as a party.

Those permitted to intervene become

parties to the proceeding, subject to any

limitations in the order granting leave to

intervene, and have the opportunity to

participate fully in the conduct of the

hearing, including the opportunity to

present evidence and cross-examine

witnesses.

If a hearing is requested, the

Commission will make a final

determination on the issue of no

significant hazards consideration. The

final determination will serve to decide

when the hearing is held.

If the final determination is that the

amendment request involves no

significant hazards consideration, the

Commission may issue the amendment

and make it immediately effective,

notwithstanding the request for a

hearing. Any hearing held would take

place after issuance of the amendment.

If the final determination is that the

amendment request involves a

significant hazards consideration, any

hearing held would take place before

the issuance of any amendment.

A request for a hearing or a petition

for leave to intervene must be filed with

the Secretary of the Commission, U.S.

Nuclear Regulatory Commission,

Washington, DC 20555–0001, Attention:

Docketing and Services Branch, or may

be delivered to the Commission’s Public

Document Room, the Gelman Building,

2120 L Street, NW., Washington, DC, by

the above date. Where petitions are filed

during the last 10 days of the notice

period, it is requested that the petitioner

promptly so inform the Commission by

a toll-free telephone call to Western

Union at 1–(800) 248–5100 (in Missouri

1–(800) 342–6700). The Western Union

operator should be given Datagram

Identification Number N1023 and the

following message addressed to Jocelyn

A. Mitchell, Acting Project Directorate

I–1: petitioner’s name and telephone

number, date petition was mailed, plant

name, and publication date and page

number of this Federal Register notice.

A copy of the petition should also be

sent to the Office of the General

Counsel, U.S. Nuclear Regulatory

Commission, Washington, DC 20555–

0001, and to Mr. Charles M. Pratt, 1633

Broadway, New York, New York 10019,

attorney for the licensee.

Nontimely filings of petitions for

leave to intervene, amended petitions,

supplemental petitions and/or requests

for hearing will not be entertained

absent a determination by the

Commission, the presiding officer or the

presiding Atomic Safety and Licensing

Board that the petition and/or request

should be granted based upon a

balancing of the factors specified in 10

CFR 2.714(a)(1) (i)–(v) and 2.714(d).

For further details with respect to this

action, see the application for

amendment dated February 1, 1996,

which is available for public inspection

at the Commission’s Public Document

Room, the Gelman Building, 2120 L

Street, NW., Washington, DC, and at the

local public document room located at

the Reference and Documents

Department, Penfield Library, State

University of New York, Oswego, New

York 13126.

Dated at Rockville, Maryland, this 14th day

of May 1996.

For the Nuclear Regulatory Commission.

Karen R. Cotton,

Acting Project Manager, Project Directorate

I–1, Division of Reactor Projects—I/II, Office

of Nuclear Reactor Regulation.

[FR Doc. 96–12617 Filed 5–17–96; 8:45 am]

BILLING CODE 7590–01–P

Nuclear Safety Research Review

Committee; Meeting

AGENCY: Nuclear Regulatory

Commission.

ACTION: Notice of meeting.

The Nuclear Safety Research Review

Committee (NSRRC) will hold its next

meeting on June 27–28, 1996. The

location of the meeting will be in rooms

1F7/9, One White Flint North (OWFN)

Building, 11555 Rockville Pike,

Rockville, MD. The meeting will be held

from 9am to 5pm on both days.

The meeting will be held in

accordance with the requirements of the

Federal Advisory Committee Act

(FACA) and will be open to the public.

The NSRRC provides advice to the

Director of the Office of Nuclear

Regulatory Research (RES) on matters of

overall management importance in the

direction of the NRC’s program of

nuclear safety research. The main

purposes of this meeting will be (1) to

discuss the March 27, 1996 NSRRC

briefing with the Commission and (2) to

review and discuss the reports and

recommendations of the Subcommittees

on Research in Support of Risk-Based

Regulation (PRA); Instrumentation and

Control (I&C) and Human Factors; and

Subcommittee on Accident Analysis.

Participants in parts of the discussion

will include senior NRC staff and other

RES technical staff as necessary.
25248 Federal Register / Vol. 61, No. 98 / Monday, May 20, 1996 / Notices

Any inquiries regarding this notice or

any subsequent changes in the status

and schedule of the meeting, may be

made to the Designated Federal Officer,

Dr. Jose Luis M. Cortez (telephone: 301–

415–6596), between 8:15 am and 5:00

pm.

Dated at Rockville, Maryland this 14th day

of May, 1996.

For the Nuclear Regulatory Commission.

Andrew L. Bates,

Federal Advisory Committee Management

Officer.

[FR Doc. 96–12611 Filed 5–17–96; 8:45 am]

BILLING CODE 7590–01–P

SECURITIES AND EXCHANGE

COMMISSION

Submission for OMB Review;

Comment Request

Upon Written Request, Copies Available

From: Securities and Exchange

Commission, Office of Filings and

Information Services, Washington,

DC 20549

Extension: Rule 17a–13 SEC File No.

270–27 OMB Control No. 3235–

0035

Notice is hereby given that pursuant

to the Paperwork Reduction Act of 1995

(44 U.S.C. 3501 et seq.), the Securities

and Exchange Commission

(‘‘Commission’’) has submitted to the

Office of Management and Budget a

request for approval of extension on the

following rule:

Rule 17a–13(b) requires that at least

once each calendar quarter, brokers and

dealers physically examine and count

all securities held and account for all

other securities not in their possession,

but subject to the broker-dealer’s control

or direction. Any discrepancies between

the broker-dealer’s securities count and

the firm’s records must be noted and,

within seven days, the unaccounted for

difference must be recorded in the

firm’s records. Rule 17a–13(c) provides

that under specified conditions, the

securities count, examination and

verification of the broker-dealer’s entire

list of securities may be conducted on

a cyclical basis rather than on a certain

date. Although Rule 17a–13 does not

require filing a report with the

Commission, the discrepancies must be

reported on the form required by Rule

17a–5.

The information obtained from Rule

17a–13 is used as an inventory control

device to monitor a broker-dealer’s

ability to account for all securities held,

in transfer, in transit, pledged, loaned,

borrowed, deposited or otherwise

subject to the firm’s control or direction.

Discrepancies between the securities

counts and the broker-dealer’s records

alert the Commission and the Self

Regulatory Organizations (‘‘SROs’’) to

those firms having problems in their

back offices.

Because of the many variations in the

amount of securities that broker-dealers

are accountable for, it is difficult to

develop a meaningful figure for the cost

of compliance with Rule 17a–13. About

fifteen percent of all registered brokers

and dealers are exempt from Rule 17a–

13. Another significant amount of firms

have minimal obligations under the rule

because they hold, or are owed few

securities. The average amount of time

consumed by complying with Rule 17a–

13 is approximately 100 hours per year.

It should be noted that most brokerdealers would engage in the activities

required by Rule 17a–13 even if they

were not required to do so.

General comments regarding the

estimated burden hours should be

directed to the Desk Officer for the

Securities and Exchange Commission at

the address below. Any comments

concerning the accuracy of the

estimated average burden hours for

compliance with Commission rules and

forms should be directed to Michael E.

Bartell, Associate Executive Director,

Office of Information Technology,

Securities and Exchange Commission,

450 Fifth Street, NW., Washington, D.C.

20549 and Desk Officer for the

Securities and Exchange Commission,

Office of Information and Regulatory

Affairs, Office of Management and

Budget, Room 3208, New Executive

Office Building, Washington, D.C.

20503.

Dated: May 13, 1996.

Margaret H. McFarland,

Deputy Secretary.

[FR Doc. 96–12597 Filed 5–17–96; 8:45 am]

BILLING CODE 8010–01–M

[Rel. No. IC–21959; International Series

Release No. 980; File No. 812–10090]

The Chase Manhattan Bank, N.A. and

Chemical Bank; Notice of Application

May 14, 1996.

AGENCY: Securities and Exchange

Commission (‘‘SEC’’).

ACTION: Notice of application for

exemption under the Investment

Company Act of 1940 (the ‘‘Act’’).

APPLICANTS: The Chase Manhattan Bank,

N.A. (‘‘Chase’’) and Chemical Bank

(‘‘Chemical’’).

RELEVANT ACT SECTIONS: Order requested

under section 6(c) of the Act for an

exemption from section 17(f) of the Act.

SUMMARY OF APPLICATION: Applicants

request an order that would amend

three prior orders granted to Chase that

permit Chase subsidiaries in Malaysia,

Mexico, and Russia to maintain in those

countries certain assets of U.S.

registered investment companies. The

requested order would substitute the

entity surviving the anticipated merger

of Chase and Chemical as the party to

which relief is granted. Chemical will

survive the merger and change its name

to ‘‘The Chase Manhattan Bank.’’

FILING DATE: The application was filed

on April 18, 1996.

HEARING OR NOTIFICATION OF HEARING: An

order granting the application will be

issued unless the SEC orders a hearing.

Interested persons may request a

hearing by writing to the SEC’s

Secretary and serving applicants with a

copy of the request, personally or by

mail. Hearing requests should be

received by the SEC by 5:30 p.m. on

June 10, 1996 by proof of service on

applicants, in the form of an affidavit or,

for lawyers, a certificate of service.

Hearing requests should state the nature

of the writer’s interest, the reason for the

request, and the issues contested.

Persons who wish to be notified of a

hearing may request notification by

writing to the SEC’s Secretary.

ADDRESSES: Secretary, SEC, 450 Fifth

Street NW., Washington, D.C. 20549.

Applicants, c/o Daniel L. Goelzer, Esq.,

Baker & McKenzie, 815 Connecticut

Avenue NW., Washington, D.C. 20006.

FOR FURTHER INFORMATION CONTACT:

Deepak T. Pai, Staff Attorney, at (202)

942–0574, or David M. Goldenberg,

Branch Chief, at (202) 942–0564

(Division of Investment Management,

Office of Investment Company

Regulation).

SUPPLEMENTARY INFORMATION: The

following is a summary of the

application. The complete application

may be obtained for a fee at the SEC’s

Public Reference Branch.

Applicants’ Representations

1. Chase is a national banking

association, regulated by the

Comptroller of the Currency under the

National Bank Act. At December 31,

1995, Chase had shareholders’ equity in

excess of $8.065 billion. Through its

Global Securities Services division,

Chase provides custody and related

services to global institutional investors,

including U.S. registered investment

companies.

2. Chemical Bank is a banking

institution, organized under the laws of

the State of New York. It is regulated as

a bank by the Superintendent of Banks

of New York, and is a member bank of